BPMCUnknownMid-Cap
Blueprint Medicines Corp Insider Trading Activity
Every SEC Form 4 insider transaction reported for Blueprint Medicines Corp (BPMC), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are BPMC insiders buying or selling?
Blueprint Medicines Corp insiders reported 2 open-market buys ($348.3K) and 246 sells ($133.5M) across 248 Form 4 filings — a net selling position of $133.2M.
Source: SEC EDGAR Form 4
Key Statistics (as of Jul 8, 2025)
Total Form 4 filings
248
SEC EDGAR
Insider filers
20
Insider buys (2)
$348.3K
Insider sells (246)
$133.5M
Insider sentiment
Net sellingNet insider flow of $133.2M in net selling.
Recent BPMC insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 8, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 1.2K | $128.25 | $150.3K |
| Jul 8, 2025 | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale | 1.1K | $128.25 | $134.8K |
| Jun 5, 2025 | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale | 2.7K | $127.88 | $340.0K |
| May 29, 2025 | Jeffrey W. Albers | Director | Sale | 5.0K | $101.14 | $505.7K |
| May 21, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 2.3K | $100.51 | $228.6K |
| May 7, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 2.3K | $101.75 | $231.4K |
| May 7, 2025 | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale | 2.8K | $103.13 | $283.8K |
| Apr 3, 2025 | Kate Haviland | CHIEF EXECUTIVE OFFICER | Sale | 2.5K | $86.65 | $216.5K |
| Mar 26, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 2.3K | $95.02 | $216.1K |
| Mar 17, 2025 | Jeffrey W. Albers | Director | Sale | 5.8K | $88.80 | $512.0K |
| Mar 14, 2025 | Jeffrey W. Albers | Director | Sale | 7.5K | $87.80 | $658.5K |
| Mar 7, 2025 | Becker L. Hewes | CHIEF MEDICAL OFFICER | Sale | 10.1K | $88.23 | $890.6K |
| Mar 7, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 6.5K | $88.80 | $576.8K |
| Mar 7, 2025 | Fouad Namouni | PRESIDENT, R & D | Sale | 6.5K | $88.80 | $576.2K |
| Mar 7, 2025 | Tracey L Mccain | EVP AND CHIEF LEGAL OFFICER | Sale | 5.3K | $88.80 | $467.3K |
| Mar 7, 2025 | Philina Lee | CHIEF COMMERCIAL OFFICER | Sale | 3.7K | $88.80 | $331.5K |
| Mar 7, 2025 | Michael Landsittel | CHIEF FINANCIAL OFFICER | Sale | 5.3K | $88.80 | $469.2K |
| Mar 7, 2025 | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale | 1.3K | $88.80 | $117.7K |
| Mar 7, 2025 | Kate Haviland | CHIEF EXECUTIVE OFFICER | Sale | 16.2K | $88.80 | $1.4M |
| Mar 7, 2025 | Debra Durso-Bumpus | CHIEF PEOPLE OFFICER | Sale | 5.2K | $88.80 | $457.9K |
| Mar 7, 2025 | Percy H. Carter | CHIEF SCIENTIFIC OFFICER | Sale | 3.5K | $88.80 | $313.5K |
| Mar 4, 2025 | Ariel Hurley | PRINCIPAL ACCOUNTING OFFICER | Sale | 3.2K | $92.62 | $296.7K |
| Feb 24, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 2.3K | $95.14 | $216.3K |
| Jan 24, 2025 | Kate Haviland | CHIEF EXECUTIVE OFFICER | Sale | 1.4K | $110.24 | $159.4K |
| Jan 24, 2025 | Christina Rossi | CHIEF OPERATING OFFICER | Sale | 2.3K | $110.14 | $250.5K |
Showing the 25 most recent of 248 Form 4 filings for Blueprint Medicines Corp.
Most active BPMC insiders
- Ariel Hurley42 filings
- Jeffrey W. Albers42 filings
- Kate Haviland22 filings
- Christina Rossi17 filings
- Becker L. Hewes14 filings
Ask anything about BPMC insider activity
Use Trabud's AI agent to query Blueprint Medicines Corp's Form 4 history in plain English — "Show me BPMC CEO purchases this year" or compare it against any other ticker.
Open the AI agentBPMC insider trading FAQ
Are Blueprint Medicines Corp insiders buying or selling?
Across 248 SEC Form 4 filings, Blueprint Medicines Corp (BPMC) insiders reported 2 open-market purchases totaling $348.3K and 246 sales totaling $133.5M. That is a net selling position of $133.2M.
How many insiders trade BPMC stock?
20 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Blueprint Medicines Corp. The most recent filing was accepted on Jul 8, 2025.
Where does Trabud get BPMC insider trading data?
All BPMC insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.